Table 2.
Characteristics | Number of Patients in Low-Tolerance (Total Days) |
Number of Patients in High-Tolerance (Total Days) |
---|---|---|
β-lactams | ||
Ampicillin | 0 | 1 (7) |
Sulbactam/Ampicillin | 0 | 2 (40) |
Clavulanic acid/Amoxicillin | 0 | 2 (6) |
Tazobactam/Piperacillin | 0 | 1 (4) |
Cefcapene pivoxil | 3 (26) | 2 (7) |
Cefazolin | 0 | 1 (6) |
Cefmetazole | 0 | 2 (13) |
Ceftriaxone | 1 (10) | 0 |
Cefozopran | 0 | 1 (5) |
Sulbactam/Cefoperazone | 1 (5) | 0 |
Ceftazidime | 0 | 3 (35) |
Meropenem | 1 (5) | 1 (3) |
Quinolones | ||
Levofloxacin | 1 (21) | 1 (4) |
Garenoxacin | 0 | 2 (12) |
Moxifloxacin | 0 | 1 (7) |
Macrolides | ||
Clarithromycin | 0 | 1 (5) |
Clindamycin | 0 | 1 (3) |
Tetracycline | ||
Minocycline | 0 | 1 (5) |
Data are presented as total number of patients. Numbers in parentheses represent total days antibiotics had been administered.